- Home
- ACCO vs ALT Comparison
ACCO vs ALT Comparison
Compare ACCO & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACCO
- ALT
- Stock Information
- Founded
- ACCO 1893
- ALT 1997
- Country
- ACCO United States
- ALT United States
- Employees
- ACCO N/A
- ALT N/A
- Industry
- ACCO Publishing
- ALT Biotechnology: Pharmaceutical Preparations
- Sector
- ACCO Consumer Discretionary
- ALT Health Care
- Exchange
- ACCO Nasdaq
- ALT Nasdaq
- Market Cap
- ACCO 487.6M
- ALT 472.3M
- IPO Year
- ACCO N/A
- ALT N/A
- Fundamental
- Price
- ACCO $5.16
- ALT $6.64
- Analyst Decision
- ACCO Buy
- ALT Strong Buy
- Analyst Count
- ACCO 1
- ALT 7
- Target Price
- ACCO $7.50
- ALT $20.83
- AVG Volume (30 Days)
- ACCO 591.1K
- ALT 2.1M
- Earning Date
- ACCO 02-20-2025
- ALT 03-26-2025
- Dividend Yield
- ACCO 5.83%
- ALT N/A
- EPS Growth
- ACCO N/A
- ALT N/A
- EPS
- ACCO N/A
- ALT N/A
- Revenue
- ACCO $1,706,700,000.00
- ALT $52,000.00
- Revenue This Year
- ACCO N/A
- ALT N/A
- Revenue Next Year
- ACCO $0.70
- ALT N/A
- P/E Ratio
- ACCO N/A
- ALT N/A
- Revenue Growth
- ACCO N/A
- ALT N/A
- 52 Week Low
- ACCO $4.37
- ALT $5.28
- 52 Week High
- ACCO $6.62
- ALT $14.84
- Technical
- Relative Strength Index (RSI)
- ACCO 43.21
- ALT 40.91
- Support Level
- ACCO $5.20
- ALT $6.15
- Resistance Level
- ACCO $5.42
- ALT $7.18
- Average True Range (ATR)
- ACCO 0.13
- ALT 0.33
- MACD
- ACCO 0.01
- ALT 0.02
- Stochastic Oscillator
- ACCO 28.95
- ALT 38.82
About ACCO Acco Brands Corporation
ACCO Brands Corp designs, manufactures, and markets consumer and business products. It operates through three segments: ACCO Brands North America, ACCO Brands EMEA, and ACCO Brands International. The company offers school notebooks, janitorial supplies, and whiteboards; storage and organization products, sheet protectors, and indexes, and punching products; computer accessories and others used in schools, homes, and businesses. It offers its products under the AT-A-GLANCE, Five Star, GBC, Hilroy, Kensington, Quartet, Leitz, NOBO and other brands. The company markets and sells its products through various channels, including mass retailers; e-tailers; discount, and variety chains; and warehouse clubs. It generates maximum profit from ACCO Brands North America segment.
About ALT Altimmune Inc.
Altimmune Inc is engaged in developing treatments for obesity and liver diseases. The Company's pipeline includes next-generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.